|
 Latest News
|
|
|
|
|
|
Medusa®
|
|
A Versatile Nano Carrier for the Delivery of Native Proteins
Medusa®, a self-assembled poly-aminoacid nanogel system, is a versatile
protein carrier for the development of novel and second-generation long-acting
native protein drugs. more info
|
|
Micropump® Technologies
|
From Pediatric to Geriatric Uses
Controlled-release systems permitting either extended (Micropump® I)
or both delayed and extended (Micropump® II) delivery of small molecule drugs.
more info
|
|
For more information about Flamel's drug delivery technologies, product development capabilities, and business
partnerships, please contact:
In Europe
Stephen H. Willard
Chief Executive Officer
e-mail: willard@flamel.com
Rafael Jorda, Ph.D.
Vice President,
Director of Manufacturing and Development
e-mail: jorda@flamel.com
Jeffery S. Vick
Chief Business Officer
e-mail: vick@flamel.com
In the USA
Nigel McWilliam,
Director, Business Development, USA
e-mail: mcwilliam@flamel.com
For regulatory matters, please contact:
Christian Kalita, Ph.D.
Quality and Regulatory Director
Qualified Person
e-mail: kalita@flamel.com
For pharmacovigilance matters, please contact:
Roger Kravtzoff, Ph.D.
Preclinical and Early Clinical Development Director
e-mail: kravtzoff@flamel.com
or
Maryline Guest, M.D.
Medical Advisor
Eu QPPV (European Qualified Person for Pharmaco Vigilance)
e-mail: guest@flamel.com
For general inquiries, please contact:
e-mail: info@flamel.com
Office Locations
Headquarters
33 avenue du Dr. Georges Levy
69693 Venissieux Cedex
France
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435
Manufacturing Facility
11 avenue Gustave Eiffel
33608 Pessac Cedex
France
Phone: +33 (0) 557 260 770
Fax: +33 (0) 556 365 891
|
